|
 |
Environment > Pharmacokinetics
The following information is about Pharmacokinetics.
Pharmacokinetics Defined
The study of the way that drugs move through the body after they are swallowed or injected.
This definition is in context to Environment. See more contextual defintions for Pharmacokinetics.
BioCis Pharma Reports Positive Phase IIa Clinical Results In Atopic Dermatitis
Published July 4, 2009, 4:09 am, Medical News Today
BioCis Pharma Ltd., a privately held drug development company with its headquarters in Turku, Finland, announced positive results from its Phase IIa clinical trial of ProtoCure(TM) emulsion cream, the company's novel topical drug for dermatology.
Research and Markets: Drug Safety Evaluation, 2nd Edition - Updated and Expanded Safety Guide to All Aspects of the ...
Published July 3, 2009, 8:12 am, Business Wire via Yahoo! Finance
DUBLIN----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Drug Safety Evaluation, 2nd Edition" to their offering.
Training Course for Propofol Administration Available Nationally
Published June 30, 2009, 5:33 pm, dBusinessNews.com
Medical News USA / Canada: Conscious Sedation Consulting announces the development of a course to educate non-anesthesia physicians and nurses in the administration of propofol.
DuoCort: New Chronotherapy For Adrenal Insufficiency
Published June 30, 2009, 5:10 am, Medical News Today
DuoCort publishes data from its Phase I study for the rare and life threatening disease adrenal insufficiency. The release profile of DuoCort's new form of treatment with once-a-day hydrocortisone dosing closely resembles the physiological secretion pattern. The data is published in the European Journal of Endocrinology, a leading scientific journal for endocrinology.
Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect In Phase IIa Trial In Nocturia
Published June 30, 2009, 4:09 am, Medical News Today
Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, announces positive results from a Phase IIa clinical trial of its lead development compound VA106483 for nocturia.
Afinitor And Sandostatin LAR Phase II Data Show Advanced Pancreatic NET Patients Remain Progression-Free For Nearly 17 ...
Published June 29, 2009, 4:09 am, Medical News Today
New data demonstrate that treatment with Afinitor® (everolimus) in combination with Sandostatin® LAR® (octreotide acetate suspension for injection) and Afinitor monotherapy may have the potential to stabilise tumour growth in patients with advanced pancreatic neuroendocrine tumours (NET).
Are you looking for additional Environment > Pharmacokinetics news? Try our new "Pharmacokinetics News Focus" area.
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Pharmacokinetics. If you would like to find related tags we recommend Tag Patterns > Pharmacokinetics
Off-site Pharmacokinetics Research Links
If you still need additional information on Pharmacokinetics then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
- A9 > Pharmacokinetics
- Alexa > Pharmacokinetics
- Anti-Aging Revolution > Pharmacokinetics
- DMOZ > Pharmacokinetics
- Feeds Filtered > Pharmacokinetics
- Google > Pharmacokinetics
- News Meme > Pharmacokinetics
- Nuah: News > Pharmacokinetics
- The Feed Directory > Pharmacokinetics
- OBP > Pharmacokinetics
- Open Tag Directory > Pharmacokinetics
- Podzy > Pharmacokinetics
- Yahoo > Pharmacokinetics
Environment Topics
Everything you need to know about Environment
Environment
If you know the Environment Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Environment.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
License
This work is licensed under Creative Commons.